AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 MAR 7 - (NewsRx.com & NewsRx.net) --
by Michelle Marble, staff medical writer -- The golden hamster will help researchers develop a vaccine against leishmaniasis, say scientists in Spain.
"For experimental infections with viscerotrophic strains of Leishmania, a suitable animal model is not yet defined," said J.M. Requena and colleagues, University Autonoma Madrid. "In the present work, we have reappraised the use of golden hamster (Mesocricetus auratus) as an experimental model for infection with Leishmania infantum."
Requena et al. published the results of their study in the journal Veterinary Immunology and Immunopathology.
The researchers challenged several groups of hamsters by the intracardial route with doses of L. infantum. The doses ranged from 10(3) to 10(5) infectious promastigotes. After being infected, the animals were monitored for a one-year follow-up period.
The authors assessed clinical symptoms, measuring parasite loads in both liver and spleen, and noting humoral response to Leishmania antigens and antibody levels in the kidneys of the infected animals. They analyzed humoral responses using either crude antigens (by enzyme-linked immunosorbent assay [ELISA] and Western blotting) or several recombinant Leishmania antigens (Hsp70, Hsp83, LiP2a, LiP2b, H2A, H3, and KMP-11).
...